Business Wire

RS Oncology Announces New Preclinical Data Show RSO-021 May Block and/or Reverse the Progression of Aggressive Mesotheliomas, Improving Druggability

Share

RS Oncology, a clinical stage biotechnology company developing innovative therapies to eradicate mesothelioma and other diseases, was part of a collaboration that recently shared new preclinical data at the IASLC 2023 World Conference on Lung Cancer in Singapore. The data, presented by Dr. Dean Fennell, represented a partnership between RS Oncology and other lead research institutions, including the University of Leicester and the Cunniff Laboratory at the University of Vermont Cancer Center.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230912702236/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

“Sarcomatoid tumors are highly resistant to anti-cancer therapies, and many patients run out of available treatment options. Our findings here might have unveiled a druggable ‘Achilles Heel’ against this terrible disease,” said Dr. Fennell, presenting author on the study. Dr. Fennell and Dr. Cunniff shown at lunch during AACR conference 2023. (Photo courtesy of George Naumov)

Mesotheliomas can transform from a less aggressive epithelioid malignancy to a more aggressive sarcomatoid form. Using biphasic mesotheliomas as a model containing both epithelioid and sarcomatoid features, investigators at the University of Leicester, led by Dr. Fennell, conducted a geospatial analysis of patient tissues to explore the molecular signatures associated with the histological regions.

Using sophisticated spatial analysis tools coupled with machine learning approaches, the group found that the more aggressive sarcomatoid regions had distinct molecular signatures driving pro-tumor pathways, drug resistance, and increased metastatic potential. These findings were validated across an independent cohort of 150 mesothelioma patient tissues. Notably, tumor regions containing sarcomatoid tissue showed features of increased resistance to oxidative stress – a critical tumor cell adaptation for survival.

In collaboration with Dr. Brian Cunniff’s laboratory, the team then evaluated molecular signatures of human biphasic mesothelioma tumor cells following treatment with the irreversible PRX3 inhibitor RSO-021, which is currently being evaluated in a Phase 1/2 clinical trial in patients with malignant pleural effusion caused by advanced/metastatic solid tumors (NCT05278975). RSO-021 treatment reversed the gene signatures associated with epithelial-to-sarcomatoid transition, including downregulation of hypoxia, glycolysis, and epithelial-to-mesenchymal transition (EMT)-associated genes. These results suggest that this transition, thought to be unidirectional in nature, may be PRX3-dependent, druggable, and now reversible.

Sarcomatoid tumors are highly resistant to anti-cancer therapies, and many patients run out of available treatment options. Our findings might have unveiled a druggable ‘Achilles Heel’ against this terrible disease,” said Dr. Fennell, presenting author on the study. “The ability to treat such tumors with RSO-021 and revert them to epithelioid malignancies could delay or even prevent emergence of the most aggressive features associated with mesothelioma. Further, RSO-021 could potentially sensitize them to other treatments.”

Presentation Details 
Abstract Number: MA17.11 
Session: MA17 - Current Standards and Future Directions in Mesothelioma 
Title: Spatial Transformation in Mesothelioma Involves a Hypoxia-TGF Beta-EMT Axis that is Reversible via PRX3 Inhibition 
Date: Tuesday, September 12, 10:45 AM UTC +8

About RS Oncology 
RS Oncology (RSO) is a clinical stage biotechnology company based in Cambridge, Massachusetts with a mission to eradicate mesothelioma and other diseases worldwide through novel science and an innovative business model.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Jarrett Duncan, CEO
j.duncan@rsoncology.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CRH Develops Wind Farm to Power Cement Plant in Romania1.11.2024 17:15:00 EET | Press release

CRH (NYSE: CRH), the leading provider of building materials solutions, has developed a new wind farm to provide renewable electricity to its Medgidia Cement Plant in Romania. The wind farm is the first of its kind in the country to exclusively power a cement plant. It will meet a significant proportion of the Medgidia Plant’s annual energy requirements, helping to lower the carbon footprint of the products it produces, while also contributing to Romania’s clean energy transition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241101943296/en/ (Photo: Business Wire) Eunice Heath, Chief Sustainability Officer, CRH, said: “This is a significant clean energy project for CRH and is one of the many ways we are helping to create a more resilient and sustainable built environment. Building a wind farm to power one of our cement plants demonstrates our commitment to decarbonizing and providing lower carbon building materials solution

Adtran and Sonic Fiber Internet partner to deliver 50G PON connectivity across California1.11.2024 15:00:00 EET | Press release

Adtran today announced its strategic collaboration with Sonic Fiber Internet to bring 50Gbit/s passive optical network (50G PON) connectivity to California. The partnership is a proactive step to ensure Sonic continues to deliver ultra-fast broadband services that meet the growing demand for higher capacity and faster speeds across the US. By leveraging Adtran’s 50G PON technology, Sonic aims to lead the industry in connectivity standards for both residential and business customers, enabling a range of applications from smart home integration and advanced entertainment streaming to frictionless remote work and high-speed business connectivity. The technology coexists with GPON and XGS-PON, providing a seamless and cost-efficient upgrade path with no service disruption, while future-proofing the network and ensuring scalability for evolving digital needs. It also supports Combo PON setups, integrating multiple generations of fiber technology to fully maximize deployment flexibility. Thi

MyGuava and Crystal Palace Launch Exciting Fan Payment Cards and Rewards1.11.2024 14:37:00 EET | Press release

MyGuava in association with Crystal Palace Football Club is thrilled to launch exclusive Crystal Palace Fan Cards with rewards and a variety of perks as well as a unique opportunity for fans to celebrate their connection to the club while enjoying MyGuava’s seamless payment solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241101068560/en/ MyGuava and Crystal Palace Launch Exciting Fan Payment Cards and Rewards (Photo: Business Wire) Palace fans can now download the MyGuava App and order a Crystal Palace Card, choosing from three custom-designed cards: ‘Palace Gold’, ‘Palace Sash’ and ‘Selhurst 100’. Each card comes packed with perks, including entry into exclusive prize draws, cashback on all purchases, giving Palace fans an opportunity to take advantage of the 7% cashback offer ahead of the festive period. Additionally, the cards come with Visa Platinum status for added financial flexibility. Furthermore, for the m

NielsenIQ (NIQ) appoints Steen Lomholt-Thomsen as Chief Commercial Officer1.11.2024 14:00:00 EET | Press release

NIQ, the world’s leading consumer intelligence company, announced the appointment of Steen Lomholt-Thomsen as its new Chief Commercial Officer, effective November 1, 2024. Steen will drive client strategy and enhance global growth as NielsenIQ expands its capabilities to deliver mission-critical insights into the most holistic view of consumer shopping behavior. NIQ’s AI capabilities, together with its core data assets and unmatched global footprint, are uniquely positioned to give clients the Full View™: a holistic view of shopper behavior. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241101505660/en/ Steen Lomholt-Thomsen NIQ Chief Commercial Officer (Photo: Business Wire) Steen brings extensive experience leading revenue growth and operational excellence in complex global organizations, including BullWall, Clarivate, and Aveva, and has held leadership roles in companies including IBM, HP, and IHS (now S&P Global). He br

Rampur Distillery Lights Up Diwali in Times Square New York City1.11.2024 12:30:00 EET | Press release

Rampur Distillery celebrates Diwali 2024 with a striking display at Times Square, New York City. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030298390/en/ This #Diwali, we lit up Times Square with Rampur Indian Single Malt Asava - Best World Whisky! (Photo: Business Wire) "Happy Diwali from all of us at Rampur Distillery! This festival symbolizes light, unity, and new beginnings. As we celebrate, we're proud to showcase our award-winning Rampur Indian Single Malt Whisky and introduce our Jugalbandi collection series, featuring Jugalbandi #5 and #6 expressions, set to launch in the United States in 2025. Times Square reflects our rich heritage and commitment to expanding our global presence. Together, let’s embrace the spirit of Diwali and look forward to a prosperous year ahead!" - Mr. Sanjeev Banga, President of International Business at Radico Khaitan. In 2016, Rampur Distillery made a significant entry into the glob

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye